A Novel Asexual Blood-Stage Malaria Vaccine Candidate: Pfripr5 Formulated with Human-Use Adjuvants Induces Potent Growth Inhibitory Antibodies
AuthID
P-00X-GT2
P-00X-GT2
© 2025 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service